NHS Framework for the NHS London Region, Branded Medicines - Tranche A
NHS England · London
Key facts
- Awarded
- 16 Jun 2020
- Contract starts
- 31 Aug 2020
- Contract ends
- 31 Aug 2022
- Procedure
- Open procedure (above threshold)
- Buyer type
- Central government
Awarded to 28 suppliers
| Supplier | Value |
|---|---|
| Takeda UK Limited | — |
| Janssen-Cilag Ltd | — |
| Merck Sharp & Dohme UK Ltd | — |
| Pfizer Ltd | — |
| Teva UK Ltd | — |
| Abbvie Ltd | — |
| Amgen Ltd | — |
| Napp Pharmaceuticals | — |
| Sandoz Ltd | — |
| Thornton & Ross Ltd | — |
| Accord-UK Ltd | — |
| Biogen | — |
| Celltrion Healthcare United Kingdom Limited | — |
| Eli Lilly & Company Ltd | — |
| Gilead Sciences Limited | — |
| Ipsen | — |
| Novartis Pharmaceuticals UK Ltd | — |
| Novo Nordisk | — |
| Roche Products Ltd | — |
| UCB Pharma Ltd | — |
| ViiV Healthcare UK Ltd | — |
| Ferring Pharmaceuticals Limited | — |
| Pharmacosmos UK Ltd | — |
| Vifor Pharma UK Limited | — |
| Bristol-Myers Squibb Pharmaceuticals Ltd | — |
| Allergan Limited | — |
| Merz Pharma UK Ltd | — |
| Merck | — |
Description
NHS Framework for the NHS London Region, Branded Medicines - Tranche A, Annual Tranche - Cytokine Modulators and other products, and Dolutegravir / Lamivudine
Offer reference number: CM/PHR/16/5516
CM/PHR/16/5516/01 - London Tranche A - 1 September 2020 to 31 August 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
CM/PHR/16/5516/02 - London Annual Tranche - Cytokine Modulators and other products - 1 September 2020 to 31 August 2021 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months
CM/PHR/16/5516/03 - NHS Framework agreement for the supply of Dolutegravir / Lamivudine - North of England - 1 September 2020 - 28 February 2021, South of England - 1 September 2020 - 31 August 2021, Midlands & East - 1 September 2020 - 28 February 2022, all with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
Categories (CPV)
- 33600000 Pharmaceutical products
Similar open tenders
Theatre/ENT Dental
Location: West MidlandsBuyer: The Shrewsbury and Telford Hospital NHS Trust
Open tenderCloses 13 Nov, 20268 daysValue £100.00kSource Find a TenderTheatre/ENT Dental Consumables
Global Travel, Accommodation and Venue Management Services
Location: North WestBuyer: Government Commercial Agency
Open tenderCloses 8 Dec, 202633 daysValue £36.25bnSource Find a TenderA framework providing comprehensive booking solutions for all UK Public Sector Travel needs, including air, rail, taxis, coaches, car hire, accommodation and venues for meetings, conferences and events, as well as emergency travel and accommodation solutions, including for civilian cohorts under the care of a UK Public
Orthotic Splints & Braces
Location: West MidlandsBuyer: The Shrewsbury and Telford Hospital NHS Trust
Open tenderCloses 13 Nov, 20268 daysValue £60.14kSource Find a TenderOrthotic Splints & Braces - RJAH, SATH , SCT
UKRI-6412 MRC Harwell Self-Steam Generating Autoclave
Location: South WestBuyer: UK Research & Innovation (UKRI)
Open tenderCloses 30 Nov, 202625 daysValue £150.00kSource Find a TenderMRC Harwell is seeking to replace the existing autoclave with the supply, installation and acceptance of a self-steaming generating autoclave
Cleanroom Consumables
Location: West MidlandsBuyer: The Shrewsbury and Telford Hospital NHS Trust
Open tenderCloses 9 Nov, 20264 daysValue £11.91kSource Find a TenderCleanroom Consumables - SATH & SCT
MED0014 - The Supply of Beating Heart Products
Location: United KingdomBuyer: University Hospitals of North Midlands NHS Trust
Open tenderCloses 16 Nov, 202611 daysValue £18.33kSource Find a TenderBeating heart surgery (Off-Pump Coronary Artery Bypass or OPCAB) utilizes specific stabilization equipment rather than a cardiopulmonary bypass machine.